A growing body of evidence suggested the contributions of coinhibitory receptors, including TIM-3, to the immune-mediated disorders.[23] Our proposed hypothesis is that the TIM-3/galectin-9 axis is implicated in maintaining the regulation of adaptive and innate immune responses in RA. The gene discussed is LGALS9; the disease is rheumatoid arthritis.